President and CEO of Merck Serono, Belén Garijo, has been appointed an independent director of L'Oréal.
Three organizations will receive part of $1.3 million in funding that German drug maker Merck KGaA and the National Multiple Sclerosis Society are distributing for MS research.
A redesigned version of an injector pen used to treat infertility is available for distribution in the United States, the manufacturer said.
The Food and Drug Administration has approved a pre-filled injector pen made by EMD Serono for infertile women, the company said Friday.
The Food and Drug Administration has approved a new means of administration for a multiple sclerosis drug, the manufacturers said.
A German drug maker is pledging millions of dollars for multiple sclerosis research, the company's U.S. subsidiary said Thursday.
A generic drug maker in India and a German pharmaceutical company will collaborate to develop biosimilars.
Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.
A pharmacy benefit manager and the U.S. subsidiary of a German drug maker have made a deal concerning a drug for multiple sclerosis.
An orally administered drug made by Genzyme for treating multiple sclerosis did not appear superior to a biotech drug already on the market, according to results of a late-stage clinical trial.
German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.
Merck KGaA division Merck Serono has appointed Belen Garijo as COO and Annalisa Jenkins as global head of drug development and medical, effective Sept. 5.
The Food and Drug Administration declined to approve a Merck KGaA drug designed to treat relapsing-remitting multiple sclerosis.
The Food and Drug Administration has extended its review period for a multiple sclerosis drug made by EMD Serono, the drug maker said Friday.
A division of German drug maker Merck KGaA has resumed its clinical trial of a...